首页|Complutense University Reports Findings in Artificial Intelligence [Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence]

Complutense University Reports Findings in Artificial Intelligence [Measurable residual disease (MRD) dynamics in multiple myeloma and the influence of clonal diversity analyzed by artificial intelligence]

扫码查看
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News - New research on Artificial Intelligenc e is the subject of a report. According to newsoriginating from Madrid, Spain, by NewsRx correspondents, research stated, “Minimal residual disease(MRD) asses sment is a known surrogate marker for survival in multiple myeloma (MM). Here, w e presenta single institution’s experience assessing MRD by NGS of Ig genes and the long-term impact of depth ofresponse as well as clonal diversity on the cl inical outcome of a large population of MM patients; 482 MMpatients at the Univ ersity of California, San Francisco (UCSF) diagnosed from 2008 to 2020 were analyzed retrospectively.”

MadridSpainEuropeArtificial Intell igenceBlood Protein DisordersCancerEmerging TechnologiesHealth and Medic ineHematologic Diseases and ConditionsHematologyHemic and Lymphatic Diseas es and ConditionsHemorrhagic DisordersHemostatic Disor-dersImmunoproliferat ive DisordersLymphoproliferative DisordersMachine LearningMultiple MyelomaMyelomaOncologyParaproteinemiasVascular Diseases and Conditions

2024

Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
年,卷(期):2024.(Aug.21)